JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zarate, E.
Right arrow Articles by Stewart, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zarate, E.
Right arrow Articles by Stewart, D. G.
Anesth Analg 2000;90:1352-1358
© 2000 International Anesthesia Research Society

AMBULATORY ANESTHESIA

A Comparison of the Costs and Efficacy of Ondansetron Versus Dolasetron for Antiemetic Prophylaxis

Eduardo Zarate, MD*, Mehernoor F. Watcha, MD{dagger}, Paul F. White, PhD, MD, FANZCA*, Kevin W. Klein, MD*, Monica Sa Rego, MD*, and D. Greg Stewart, MS*

*Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas; and {dagger}Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania

Address correspondence to Paul F. White, PhD, MD, FANZCA, Department of Anesthesiology and Pain Management, University of Texas Southwestern Medical Center at Dallas, 5161 Harry Hines Blvd., CS2.126, Dallas, TX 75235-9068. Address e-mail to pwhite{at}mednet.swmed.edu

The optimal dose and timing of 5-HT3 antagonist administration for prophylaxis against postoperative nausea and vomiting (PONV) remains controversial. Although 5-HT3 antagonists seem to be most effective when administered near the end of surgery, there are no data on the comparative efficacy or costs associated with the 5-HT3 antagonists dolasetron and ondansetron when administered at the end of the operation. In this double-blinded study, 200 outpatients undergoing otolaryngologic procedures with a standardized general anesthetic received 4 (O4) or 8 mg (O8) of ondansetron or 12.5 (D12.5) or 25 mg (D25) of dolasetron IV within 30 min before the end of surgery. A blinded observer recorded the emetic episodes, maximum nausea score, recovery room resource and drug use, nursing time spent managing PONV, times to achieve discharge criteria from the Phase 1 and 2 recovery units, postdischarge emesis, and patient satisfaction. Total costs were calculated by using the perspective of a free-standing surgicenter. There were no differences in patient demographics, incidence of PONV, need for rescue medications, time spent in the recovery areas, unanticipated hospital admissions, or patient satisfaction among the four treatment groups. The mean total costs (95% confidence intervals) to prevent PONV in one patient were lowest in the D12.5 group: $23.89 (17.18–28.79) vs $37.81 (30.29–45.32), $33.91 (28.92–39.35), and $75.18 (61.13–89.24) for D25, O4, and O8, respectively. Excluding nursing labor costs did not alter this finding: $18.51 (14.18–22.85), $34.77 (28.03–41.49), $31.77 (28.92–39.35), and $71.76 (58.17–85.35) for D12.5, D25, O4, and O8, respectively. We conclude that 12.5 mg of dolasetron IV is more cost effective than 4 mg of ondansetron IV for preventing PONV after otolaryngologic surgery and is associated with similar patient satisfaction.

Implications: When administered at the end of surgery, 12.5 mg of dolasetron IV is as effective as 25 mg of dolasetron IV, 4 mg of ondansetron IV, and 8 mg of ondansetron IV in preventing emetic symptoms after otolaryngologic surgery and was associated with similar patient satisfaction at a reduced cost. There were no differences in the antiemetic efficacy of the 4 and 8 mg doses of ondansetron.




This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. M Wilhelm, M. L Dehoorne-Smith, and P. B Kale-Pradhan
Prevention of Postoperative Nausea and Vomiting
Ann. Pharmacother., January 1, 2007; 41(1): 68 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. M. Richman, S. S. Liu, G. Courpas, R. Wong, A. J. Rowlingson, J. McGready, S. R. Cohen, and C. L. Wu
Does Continuous Peripheral Nerve Block Provide Superior Pain Control to Opioids? A Meta-Analysis
Anesth. Analg., January 1, 2006; 102(1): 248 - 257.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. F. White
Treatment of Postoperative Nausea and Vomiting with Dolasetron Versus Ondansetron: Is There a Conflict of Interest?
Anesth. Analg., December 1, 2005; 101(6): 1887 - 1887.
[Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
J. Golembiewski, E. Chernin, and T. Chopra
Prevention and treatment of postoperative nausea and vomiting
Am. J. Health Syst. Pharm., June 15, 2005; 62(12): 1247 - 1260.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
P. F. White
Update on ambulatory anesthesia
Can J Anesth, June 1, 2005; 52(suppl_1): R10 - R10.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. A. Meyer, C. R. Roberson, M. H. Rajab, J. Davis, and C. H. McLeskey
Dolasetron Versus Ondansetron for the Treatment of Postoperative Nausea and Vomiting
Anesth. Analg., February 1, 2005; 100(2): 373 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
A. S. Habib, H. E. El-Moalem, and T. J. Gan
The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials: [L'efficacite de la combinaison des antagonistes des recepteurs 5-HT3 et du droperidol ou de la dexame- thasone est similaire pour prevenir les NVPO. Une meta-analyse d'essais randomises et controles]
Can J Anesth, April 1, 2004; 51(4): 311 - 319.
[Abstract] [Full Text] [PDF]

Home page
 Canadian J. AnesthesiaHome page
A. S. Habib and T. J. Gan
Evidence-based management of postoperative nausea and vomiting: a review: [Le traitement des nausees et des vomissements postoperatoires fonde sur des donnees probantes : une revue]
Can J Anesth, April 1, 2004; 51(4): 326 - 341.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
O. Olutoye, E. C. Jantzen, R. Alexis, D. Rajchert, M. S. Schreiner, and M. F. Watcha
A Comparison of the Costs and Efficacy of Ondansetron and Dolasetron in the Prophylaxis of Postoperative Vomiting in Pediatric Patients Undergoing Ambulatory Surgery
Anesth. Analg., August 1, 2003; 97(2): 390 - 396.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
A. Recart, T. Issioui, P. F. White, K. Klein, M. F. Watcha, L. Stool, and M. Shah
The Efficacy of Celecoxib Premedication on Postoperative Pain and Recovery Times After Ambulatory Surgery: A Dose-Ranging Study
Anesth. Analg., June 1, 2003; 96(6): 1631 - 1635.
[Abstract] [Full Text] [PDF]

Home page
 Crit Care NurseHome page
K. Garrett, K. Tsuruta, S. Walker, S. Jackson, and M. Sweat
Managing Nausea and Vomiting: Current Strategies
Crit. Care Nurse, February 1, 2003; 23(1): 31 - 50.
[Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. A. Burmeister, T. G. Standl, M. Wintruff, P. Brauer, I. Blanc, and J. Schulte am Esch
Dolasetron prophylaxis reduces nausea and postanaesthesia recovery time after remifentanil infusion during monitored anaesthesia care for extracorporeal shock wave lithotripsy
Br. J. Anaesth., February 1, 2003; 90(2): 194 - 198.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. J. Sanchez-Ledesma, L. Lopez-Olaondo, F. J. Pueyo, F. Carrascosa, and A. Ortega
A Comparison of Three Antiemetic Combinations for the Prevention of Postoperative Nausea and Vomiting
Anesth. Analg., December 1, 2002; 95(6): 1590 - 1595.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Issioui, K. W. Klein, P. F. White, M. F. Watcha, M. Coloma, G. D. Skrivanek, S. B. Jones, K. C. Thornton, and B. F. Marple
The Efficacy of Premedication with Celecoxib and Acetaminophen in Preventing Pain After Otolaryngologic Surgery
Anesth. Analg., May 1, 2002; 94(5): 1188 - 1193.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
T. J. Gan
Postoperative Nausea and Vomiting--Can It Be Eliminated?
JAMA, March 13, 2002; 287(10): 1233 - 1236.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
X. Chen, J. Tang, P. F. White, R. H. Wender, R. Quon, A. Sloninsky, R. Naruse, R. Kariger, T. Webb, and E. Norel
The Effect of Timing of Dolasetron Administration on its Efficacy as a Prophylactic Antiemetic in the Ambulatory Setting
Anesth. Analg., October 1, 2001; 93(4): 906 - 911.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
H. R. Munoz, J. A. Dagnino, and B. Larsen
Power Analysis with More than Two Groups
Anesth. Analg., March 1, 2001; 92(3): 797 - 797.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2000 by the International Anesthesia Research Society.